

Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
|---|---|---|---|---|---|---|---|---|---|
| Hereditary angioedemas | D054179 | EFO_0004131 | — | 2 | 2 | 2 | — | — | 5 |
| Angioedema | D000799 | EFO_0005532 | T78.3 | 2 | 2 | 2 | — | — | 5 |
| Drug common name | Avoralstat |
| INN | avoralstat |
| Description | Avoralstat is a small molecule pharmaceutical. It is currently being investigated in clinical studies. It is known to target plasma kallikrein. |
| Classification | Small molecule |
| Drug class | enzyme inhibitors: 1) kallikrein inhibitors or 2) serine protease inhibitors |
| Image (chem structure or protein) | ![]() |
| Structure (InChI/SMILES or Protein Sequence) | C=Cc1cc(C(=O)Nc2ccc(C(=N)N)cc2)c(-c2ccc(C(=O)NCC3CC3)nc2C(=O)O)cc1OC |
| PDB | — |
| CAS-ID | 918407-35-9 |
| RxCUI | — |
| ChEMBL ID | CHEMBL4297502 |
| ChEBI ID | — |
| PubChem CID | — |
| DrugBank | — |
| UNII ID | UX17773O15 (ChemIDplus, GSRS) |
